Search research articles
Contact Us
Filters
Showing results (31-40 of 256) with videos related to
Page
of 26
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 26, 2022
Long-term stability of PASI <3 response to tildrakizumab: Pooled analyses from reSURFACE 1 and reSURFACE 2 phase 3 trials through 5 years
Diamant Thaçi, Stefano Piaserico, Kristian Gaarn Du Jardin, et al.
JAMA Dermatology
|
May 21, 2020
Melanoma Risk in Patients Treated With Biologic Therapy for Common Inflammatory Diseases: A Systematic Review and Meta-analysis
Shamarke Esse, Kayleigh J Mason, Adele C Green, et al.
American Journal of Clinical Dermatology
|
July 2, 2020
Progress to Date in Advancing Stratified Medicine in Psoriasis
Claire Reid, Lis Cordingley, Richard B Warren, et al.
Biomolecules
|
May 24, 2024
Functional Genomics and Insights into the Pathogenesis and Treatment of Psoriasis
Elan May Shellard, Shraddha S Rane, Stephen Eyre, et al.
Genome Medicine
|
July 30, 2009
Genetic susceptibility to psoriasis: an emerging picture
Rhodri Ll Smith, Richard B Warren, Christopher Em Griffiths, et al.
Dermatology and Therapy
|
March 5, 2025
Population Pharmacokinetic-Pharmacodynamic (popPK/PD) Relationship of Orismilast, A Potent and Selective PDE4B/D Inhibitor, in Atopic Dermatitis
Richard B Warren, Anne Weiss, Jakob Felding, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 3, 2025
Switching back to originator adalimumab from biosimilars in psoriasis: A cohort study from BADBIR
Duc Binh Phan, Mark Lunt, Richard B Warren, et al.
Journal of Human Genetics
|
December 21, 2017
Genotypic variability-based genome-wide association study identifies non-additive loci HLA-C and IL12B for psoriasis
Wen-Hua Wei, Jonathan Massey, Jane Worthington, et al.
International Journal of Molecular Sciences
|
December 17, 2024
Characterising a Novel Therapeutic Target for Psoriasis, TYK2, Using Functional Genomics
Shraddha S Rane, Sarah Elyoussfi, Elan Shellard, et al.
Dermatology and Therapy
|
August 27, 2020
Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis
Alice B Gottlieb, Valerie Ciaravino, Christopher Cioffi, et al.
Page
of 26
Search research articles
Search
Showing results (31-40 of 256) with videos related to
Sort By:
Page
of 26
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 26, 2022
Long-term stability of PASI <3 response to tildrakizumab: Pooled analyses from reSURFACE 1 and reSURFACE 2 phase 3 trials through 5 years
Diamant Thaçi, Stefano Piaserico, Kristian Gaarn Du Jardin, et al.
JAMA Dermatology
|
May 21, 2020
Melanoma Risk in Patients Treated With Biologic Therapy for Common Inflammatory Diseases: A Systematic Review and Meta-analysis
Shamarke Esse, Kayleigh J Mason, Adele C Green, et al.
American Journal of Clinical Dermatology
|
July 2, 2020
Progress to Date in Advancing Stratified Medicine in Psoriasis
Claire Reid, Lis Cordingley, Richard B Warren, et al.
Biomolecules
|
May 24, 2024
Functional Genomics and Insights into the Pathogenesis and Treatment of Psoriasis
Elan May Shellard, Shraddha S Rane, Stephen Eyre, et al.
Genome Medicine
|
July 30, 2009
Genetic susceptibility to psoriasis: an emerging picture
Rhodri Ll Smith, Richard B Warren, Christopher Em Griffiths, et al.
Dermatology and Therapy
|
March 5, 2025
Population Pharmacokinetic-Pharmacodynamic (popPK/PD) Relationship of Orismilast, A Potent and Selective PDE4B/D Inhibitor, in Atopic Dermatitis
Richard B Warren, Anne Weiss, Jakob Felding, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 3, 2025
Switching back to originator adalimumab from biosimilars in psoriasis: A cohort study from BADBIR
Duc Binh Phan, Mark Lunt, Richard B Warren, et al.
Journal of Human Genetics
|
December 21, 2017
Genotypic variability-based genome-wide association study identifies non-additive loci HLA-C and IL12B for psoriasis
Wen-Hua Wei, Jonathan Massey, Jane Worthington, et al.
International Journal of Molecular Sciences
|
December 17, 2024
Characterising a Novel Therapeutic Target for Psoriasis, TYK2, Using Functional Genomics
Shraddha S Rane, Sarah Elyoussfi, Elan Shellard, et al.
Dermatology and Therapy
|
August 27, 2020
Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis
Alice B Gottlieb, Valerie Ciaravino, Christopher Cioffi, et al.
Page
of 26